Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone induction in primary care
ISRCTN31125511Phase 3Completed
- Sponsor
- ANRS
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by ANRS. Primary endpoints: Daily opioid use and Prevalence of opioid users. Started Jan 2009; status: completed.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ISRCTN31125511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31125511.